lak cell

Very Low / Technical
UK/ˌɛl eɪ ˈkeɪ ˌsɛl/US/ˌɛl eɪ ˈkeɪ ˌsɛl/

Specialized / Medical / Oncology / Immunology

My Flashcards

Definition

Meaning

A type of immune cell (lymphokine-activated killer cell) produced in laboratories by exposing lymphocytes to interleukin-2, used to target and destroy cancer cells.

In broader medical contexts, refers to a method of adoptive cell transfer therapy where a patient's own immune cells are enhanced ex vivo to improve their cancer-fighting capabilities.

Linguistics

Semantic Notes

Always used as a compound noun. The 'lak' is an acronym (lymphokine-activated killer) and is not typically capitalised in running text. It denotes a laboratory-generated therapeutic agent rather than a naturally occurring cell type.

Dialectal Variation

British vs American Usage

Differences

No significant lexical differences. Spelling and terminology conventions follow general medical English norms (e.g., 'therapy' vs 'therapeutics', 'centre' vs 'center' in institutional names).

Connotations

Identical technical meaning. May be referenced more frequently in UK contexts within 'haematology' and in US contexts within 'hematology/oncology' literature.

Frequency

Extremely rare outside specialised clinical trial reports, immunology research papers, and advanced oncology textbooks in both variants.

Vocabulary

Collocations

strong
LAK cell therapygenerate LAK cellsinfuse LAK cellsLAK cell activityLAK cell infusion
medium
cultured LAK cellspatient's LAK cellswith LAK cellsLAK cell treatmentproduction of LAK cells
weak
clinical trialinterleukin-2adoptive transfertumour targetsimmune response

Grammar

Valency Patterns

The researchers generated LAK cells from the patient's blood.LAK cell therapy was administered alongside interleukin-2.The activity of the LAK cells was measured against the tumour line.

Vocabulary

Synonyms

Strong

activated lymphocyte therapyex vivo activated cell product

Neutral

lymphokine-activated killer cell

Weak

cellular immunotherapyadoptive cell transfer product

Vocabulary

Antonyms

naïve lymphocyteunstimulated lymphocytesuppressor T cell

Phrases

Idioms & Phrases

  • None. Term is purely technical.

Usage

Context Usage

Business

Virtually never used. Potentially in biotech investment reports discussing historical cancer immunotherapy approaches.

Academic

Primary context. Found in immunology, oncology, and biomedical science journals, especially in historical or methodological sections.

Everyday

Never used.

Technical

Core context. Used in clinical protocols, laboratory manuals, pharmaceutical research, and medical conference presentations on immunotherapy.

Examples

By Part of Speech

verb

British English

  • The team will LAK-cell the sample on day three.
  • We are planning to LAK-cell the patient's lymphocytes.

American English

  • The protocol involved LAK-cell-ing the harvested T-cells.
  • They decided to LAK-cell the culture to boost cytotoxicity.

adverb

British English

  • The lymphocytes were treated LAK-cell-ly to enhance potency.
  • The tumour regressed LAK-cell-ly after the infusion.

American English

  • The cells were activated LAK-cell-ly in the bioreactor.
  • The response occurred LAK-cell-ly, consistent with the mechanism.

adjective

British English

  • The LAK-cell preparation showed promising activity.
  • We observed a LAK-cell-mediated response in the model.

American English

  • The LAK-cell product was infused over two hours.
  • Researchers published the LAK-cell trial results.

Examples

By CEFR Level

A2
  • (Not applicable for this highly technical term.)
B1
  • (Not applicable for this highly technical term.)
B2
  • Scientists can make special cancer-fighting cells called LAK cells in the lab.
  • LAK cell therapy is a type of treatment that uses the body's own immune cells.
C1
  • The clinical trial investigated the efficacy of autologous LAK cells combined with high-dose interleukin-2 for metastatic melanoma.
  • Despite early promise, LAK cell therapies have been largely superseded by more specific approaches like CAR-T cells.

Learning

Memory Aids

Mnemonic

Think: 'Lymphocytes Are Kickstarted' to become killer cells. LAK = Lymphokine-Activated Killer.

Conceptual Metaphor

THE IMMUNE SYSTEM IS AN ARMY / THERAPY IS A TRAINING PROGRAMME: The body's soldier cells (lymphocytes) are taken out, given special training (activated with lymphokines), and sent back in to fight cancer.

Watch out

Common Pitfalls

Translation Traps (for Russian speakers)

  • Avoid translating 'cell' as 'ячейка' or 'камера'. The correct biological term is 'клетка' (LAK-клетка).
  • The acronym 'LAK' is used internationally; do not try to transliterate it or create a Russian acronym.
  • Be careful with 'killer' – it does not imply 'убийца' in a criminal sense but 'киллерская клетка' in a strict immunological context.

Common Mistakes

  • Writing 'LACK cell' (confusion with the English word 'lack').
  • Using as a plural without 's' (e.g., 'five LAK cell' instead of 'five LAK cells').
  • Capitalising the entire term as 'LAK CELL' in mid-sentence.
  • Confusing with 'NK cell' (natural killer cell), which is a different, naturally occurring type.

Practice

Quiz

Fill in the gap
The older immunotherapy approach involved harvesting a patient's lymphocytes, activating them with interleukin-2 to create , and then reinfusing them.
Multiple Choice

What does the 'LA' in LAK cell stand for?

FAQ

Frequently Asked Questions

No. LAK cells do not exist naturally. They are created in a laboratory by treating a patient's own lymphocytes (a type of white blood cell) with the signalling molecule interleukin-2, which 'activates' them and enhances their ability to kill cancer cells.

Both are adoptive cell therapies. LAK therapy uses a broad mixture of immune cells non-specifically activated by a cytokine (IL-2). CAR-T therapy is more precise: a patient's T-cells are genetically engineered to express a Chimeric Antigen Receptor (CAR) that targets a specific protein on cancer cells.

While pioneering, LAK therapy often showed significant toxicity (mainly from the high-dose IL-2 required) and modest efficacy for solid tumours. Newer, more targeted immunotherapies like checkpoint inhibitors and CAR-T cells have demonstrated better risk-benefit profiles, making LAK therapy largely of historical interest.

Rarely. In highly specialised contexts, professionals might say 'the patient received LAK and IL-2'. However, it is almost always followed by 'cell' or 'therapy' for clarity (LAK cell, LAK therapy). It functions as an attributive noun/adjective.